Ropivacaine
Drug ingredientActive ShortageCAS 84057-95-4
This drug ingredient is in active FDA shortage. At least one manufacturer cannot meet demand.
This chemical is not on EPA’s Toxic Substances Control Act inventory, the list behind EPA’s production survey.
Why supply is unknownProduction is reported production, not a complete census of factories. Import value and source-country shares describe a shared customs category, not a separate chemical measurement.
Where It Comes From
Customs basis: HS 293339 · basket
These shares come from HS customs code 293339, which covers 397 tracked chemicals in total. They estimate the category's origin mix, not this chemical specifically.
- Taiwan
- Ukraine
- Sweden
- Argentina
- Canada
- Finland
- Malta
- Israel
- Netherlands
- Denmark
- United Arab Emirates
- Mexico
- Brunei
- Slovakia
- Australia
- South Africa
- Poland
- Latvia
- Lithuania
- Estonia
- Slovenia
- Czech Republic
- Croatia
- Hong Kong
1 FDA-registered drug labeler
Why It Matters
- Current shortage
Ropivacaine Hydrochloride Injection
Shortage listed since March 23, 2018
Manufacturer reports: 1 unavailable, 1 limited, 3 available
Chemical Identity
Data Sources
- PubChem · compound 175805Retrieved 2026-04-07
- FDA National Drug Code directoryRetrieved 2026-04-25
- FDA Drug ShortagesRetrieved 2026-10-04
- US Census international tradeReporting year: 2024 · Retrieved 2026-10-04
Brief citations
Ropivacaine (CAS 84057-95-4) https://chemicalindependence.com/chemical/84057-95-4/ PubChem: 175805. Retrieved 2026-04-07. https://pubchem.ncbi.nlm.nih.gov/compound/175805 FDA National Drug Code directory: CAS 84057-95-4. Retrieved 2026-04-25. https://open.fda.gov/data/ndc/ FDA Drug Shortages: CAS 84057-95-4. Retrieved 2026-10-04. https://www.accessdata.fda.gov/scripts/drugshortages/ US Census international trade: HS 293339 for CAS 84057-95-4. Reporting year: 2024. https://usatrade.census.gov/